.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Continuing Education

Pharmacist Education

Physician Education

Discussing Clinical and Payer Insights to Encourage the Adoption of Oncology Biosimilars into Practice

Classify the core concepts that drive the biosimilar approval process and identify how it differs from the approval of an originator biologic.

Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions

This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.

Use of Oncology Supportive Care Biosimilars During COVID-19: Clinical Strategies for Pharmacists

This activity will provide pharmacists with an overview of growth factor biosimilars, with an emphasis on use for neutropenia and alternative approaches during the pandemic.

Incorporating the Use of Biosimilars into Clinical Practice: Opportunities for Pharmacists to Intervene

This activity will review the approval process and required nomenclature for biosimilars as well as the differences between biosimilars and biologics.